From the Journals
Risk assessment first urged for fragility fracture screening
A new guideline is aimed at primary care practitioners for their community-dwelling patients aged 40 and older.
AHA statement targets nuance in CVD risk assessment of women
Considering nonbiological and social factors when assessing CVD risk in women, particularly women of diverse races and ethnicities, is highlighted...
New guidelines for cannabis in chronic pain management released
New clinical practice guidelines for cannabis in chronic pain management may help clinicians offer an effective and less addictive alternative to...
USPSTF recommends against routine herpes screening for asymptomatic teens and adults
The updated recommendation confirms that harms outweigh benefits for population-based genital HSV screening.
New osteoporosis guideline says start with a bisphosphonate
Initial therapy with bisphosphonates for postmenopausal women with osteoporosis and men with osteoporosis are strongly recommended.
USPSTF holds firm on postmenopausal hormone recommendations
The central message of updated recommendations from the U.S. Preventive Services Task Force’s on using hormone therapy to prevent chronic...
Docs gain new flexibility treating osteoporosis from steroids
In an updated guideline, the American College of Rheumatology made two important updates for prevention and treatment of glucocorticoid-induced...
WPATH removes age limits from transgender treatment guidelines
Depending on interpretation, the latest version of the WPATH standards of care for transgender youth could be seen to have abandoned age limits on...
New ovulatory disorder classifications from FIGO replace 50-year-old system
Once an ovulatory disorder has been diagnosed, four basic categories provide a framework for classification.
NAMS affirms value of hormone therapy for menopausal women
Recent research supports individualized care to maximize benefits and minimize risks.
Evidence still lacking that vitamins prevent CVD, cancer: USPSTF
In its final recommendation statement on the subject, the task force does, however, recommend against use of vitamin E and beta-carotene.